Premenstrual Dysphoric Disorder (PMDD)TDPMNCT07864285
Occupational Physicians Facing Premenstrual Dysphoric Disorder: Knowledge, Perceptions and Practices in Occupational Health
An observational study of Premenstrual Dysphoric Disorder (PMDD), run by University Hospital, Strasbourg, France at 1 site in France.
Trial summary
This study aims to assess the knowledge, perceptions and practices of occupational physicians regarding premenstrual dysphoric disorder (PMDD), a condition with significant occupational impact that remains insufficiently explored in occupational health. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Premenstrual Dysphoric Disorder (PMDD)
- How many people
- 15 participants
- Where
- 1 siteFrance
- Study dates
- 9 Mar 2026to 9 Mar 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Occupational physicians practicing in France participating in semi-structured interviews on PMDD in occupational health practice.
Who may be able to join
- Occupational physicians or occupational health collaborators
- Practicing in France for at least two years
- Agreeing to participate in the study
Who cannot join
- Lack of proficiency in the French language
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Service de Psychiatrie 2 - CHU de Strasbourg - France
Strasbourg, 67091
Sébastien WEIBEL, MD, PhD
Clémentine RAGONDET, MD
About this study
This study aims to assess the knowledge, perceptions and practices of occupational physicians regarding premenstrual dysphoric disorder (PMDD), a condition with significant occupational impact that remains insufficiently explored in occupational health.
- Conditions
- Premenstrual Dysphoric Disorder (PMDD)
- Keywords
- PMDD, Occupational health, Menstrual disorders
- Medical subject headings
- Premenstrual Dysphoric Disorder, Menstruation Disturbances
What is being measured
The primary outcome is the main question the study is designed to answer.
Knowledge and perceptions of occupational physicians regarding PMDD
Qualitative evaluation of knowledge, perceptions and understanding of PMDD among occupational physicians through semi-structured interviews
Measured: During data collection period in 2026
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Oct 2026
- Study start9 Mar 2026
- Primary completion9 Dec 2026 (estimated)
- Study completion9 Mar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Premenstrual Dysphoric Disorder (PMDD)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 15 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07864285
- Sponsor's protocol ID
- 9825
- Acronym
- TDPM
- Status last verified
- Oct 2026
- First submitted
- 2 Oct 2026
- Last updated
- 7 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Occupational Physicians Facing Premenstrual Dysphoric Disorder: Knowledge, Perceptions and Practices in Occupational Health
- ClinicalTrials.gov ID
- NCT07864285
- Acronym / sponsor ID
- TDPM / 9825
- Conditions
- Premenstrual Dysphoric Disorder (PMDD)
- Keywords
- PMDD, Occupational health, Menstrual disorders
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 15 participants (estimated)
- Lead sponsor
- University Hospital, Strasbourg, FranceUniversity, hospital or other
- Study start
- 9 Mar 2026 (actual)
- Primary completion
- 9 Dec 2026 (estimated)
- Study completion
- 9 Mar 2027 (estimated)
- First posted
- 7 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to assess the knowledge, perceptions and practices of occupational physicians regarding premenstrual dysphoric disorder (PMDD), a condition with significant occupational impact that remains insufficiently explored in occupational health.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Occupational physicians practicing in France participating in semi-structured interviews on PMDD in occupational health practice.
Key inclusion criteria (3 listed)
- Occupational physicians or occupational health collaborators
- Practicing in France for at least two years
- Agreeing to participate in the study
Key exclusion criteria (1 listed)
- Lack of proficiency in the French language
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Knowledge and perceptions of occupational physicians regarding PMDD
Time frame: During data collection period in 2026
Qualitative evaluation of knowledge, perceptions and understanding of PMDD among occupational physicians through semi-structured interviews
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Oct 2026.
Related trials for Premenstrual Dysphoric Disorder (PMDD)
Enrolling by invitation
Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause
Perimenopause, PMDD
Not yet recruitingPhase 1
MLS101 Study in PMDD
Premenstrual Dysphoric Disorder ( PMDD), PMDD
Not yet recruitingObservational study
The SPARK-PMDD Study
Premenstrual Dysphoric Disorder, PMDD
RecruitingObservational study
To Establish Whether Individuals With Premenstrual Dysphoric Disorder (PMDD) Demonstrate a Different Luteal-phase Sex Hormone Profile and Ratio Compared With Asymptomatic Controls.
Premenstrual Dysphoric Disorder ( PMDD)
RecruitingObservational study
CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life
Premenstrual Syndrome, Premenstrual Dysphoric Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Premenstrual Dysphoric Disorder (PMDD), run by University Hospital, Strasbourg, France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Sébastien WEIBEL, MD, PhD (33 3 88 11 51 57, sebastien.weibel@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Knowledge and perceptions of occupational physicians regarding PMDD (time frame: During data collection period in 2026). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.